A Multicenter Real World Study of Kanglaite for Cancer Cachexia
- Conditions
- Cancer Cachexia
- Interventions
- Drug: Kanglaite Injection/Capsules
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Zhejiang Kanglaite Pharmaceutical Co.Ltd
- Target Recruit Count
- 100000
- Registration Number
- NCT03631459
- Locations
- 🇨🇳
Peking University International Hospital, Beijing, Beijing, China
🇨🇳NanJing PLA 81 Hospital, Nanjing, Jiangsu, China
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Phase 4
- Conditions
- Cancer Cachexia
- Interventions
- Drug: Kanglaite Injection
- First Posted Date
- 2015-09-17
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Zhejiang Kanglaite Pharmaceutical Co.Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT02553187
- Locations
- 🇨🇳
Cancer Center, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
© Copyright 2025. All Rights Reserved by MedPath